Gastrointestinal Cancer News

Survival and recurrence rates were unaffected by HIV infection among patients who underwent liver transplantation for hepatocellular carcinoma, according to a poster presentation at CROI 2015.

The addition of trastuzumab to the standard first-line regimen of capecitabine plus oxaliplatin created a highly effective and well-tolerated combination for the treatment of advanced gastric cancer, according to results of a phase 2 study.

Cigarette smoking is associated with a higher mortality rate among patients with invasive, nonmetastatic colorectal cancer, according to results of a study led by investigators from the American Cancer Society.

The use of statins decreased the risk for primary liver cancer, especially in patients with liver disease and diabetes, according to newly published data.

The location of tumors in the colon may be an important prognostic factor for patients with treatment-naive metastatic colorectal cancer, according to study results.

Nexavar and transarterial chemoembolization combination therapy for advanced hepatocellular carcinoma was well tolerated by elderly patients, according to study data.

Updated results from the HEAT Study indicated an increased overall survival rate among patients with primary liver cancer when treated with ThermoDox combined with radiofrequency ablation, according to a press release.

Liver transplant recipients were at increased risk for hepatocellular carcinoma recurrence if they received a liver from a donor aged at least 60 years or from a nonlocal share distribution, according to study data.

The FDA granted orphan drug status to pelareorep for the treatment of pancreatic cancer, the drug’s manufacturer announced today.

High-resolution microendoscopy with quantitative image analysis was useful for identifying esophageal squamous neoplasia with high sensitivity and specificity, according to recent study data.